Eleni Zografos
No ORCID on file
· 1 paper in corpus
observational
2022
BACKGROUND: Germline BRCA1/2 mutations are identified in 13-15% of ovarian cancers, while an additional 5-7% of ovarian cancers harbor somatic BRCA1/2 mutations. Beyond these mutations, germline or somatic aberrations in genes of the homolo…